McKesson   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: New York NY United States (1833)
Status: No NME R&D (1833)

Organization Overview

First Clinical Trial
2017
NCT03379428
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

US Oncology Research | US Oncology Research/McKesson Specialty Health